Milestone Pharmaceuticals Inc. (MIST) Misses Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts MIST Hot Sheet
Join SI Premium – FREE
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q4 EPS of ($0.19), $0.03 worse than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Smith Says Starboard Has Taken A Position In Shake Shack - Bloomberg
- Benchmark Reiterates Buy Rating on AMD (AMD)
- National Retail Properties (NNN) Tops Q2 EPS by 1c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
